Exact Sciences Corp. (EXAS) News
Filter EXAS News Items
EXAS News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
EXAS News Highlights
- For EXAS, its 30 day story count is now at 22.
- Over the past 22 days, the trend for EXAS's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
- AMP, AGE and DX are the most mentioned tickers in articles about EXAS.
Latest EXAS News From Around the Web
Below are the latest news stories about EXACT SCIENCES CORP that investors may wish to consider to help them evaluate EXAS as an investment opportunity.
EXAS Stock Is a Hidden Gem in the Healthcare Sector for Bold InvestorsPatient investors who have room for an intriguing medical-niche investment in their portfolio should take a closer look at EXAS stock. |
If You Invested $10,000 in Exact Sciences in 2018, This Is How Much You Would Have TodayExact Sciences (NASDAQ: EXAS) is a cancer diagnostics company with promising long-term potential. Its Cologuard non-invasive test can detect colorectal cancer and help save lives. Below, I'll look at what a $10,000 investment in Exact Sciences made in 2018 would be worth now, and whether the healthcare stock is a good buy today. |
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare SectorTo play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy. |
Exact Sciences (EXAS) Stock Moves -0.16%: What You Should KnowIn the latest trading session, Exact Sciences (EXAS) closed at $64.36, marking a -0.16% move from the previous day. |
7 Growth Stocks Sitting in a Sweet SpotFor instance, these seven growth stocks. |
Exact Sciences (EXAS) Gains But Lags Market: What You Should KnowIn the latest trading session, Exact Sciences (EXAS) closed at $64.46, marking a +1.45% move from the previous day. |
Cathie Wood Watch: Ark Buys Block, TeslaWood's flagship Ark Innovation ETF has lost 28% during the last year, but has bounced back 21% so far this year. |
A Nasdaq Bull Market Is Coming: 2 Revolutionary Stocks to Buy and HoldLast year, the Nasdaq Composite fell into a bear market and lagged behind the other two major U.S. market indexes. Let's consider two revolutionary companies to invest in before that happens: Moderna (NASDAQ: MRNA) and Exact Sciences (NASDAQ: EXAS). Moderna became widely known during the pandemic for being one of the leaders in the coronavirus vaccine market. |
Cathie Wood Watch: Another Day, Another Coinbase BuyWood's flagship Ark Innovation ETF fell 42% during the past year, but has bounced back 15% so far this year. |
Cathie Wood Watch: Ark Dives Back in to Tesla SharesWood's flagship Ark Innovation ETF has dropped 36% over the past year but has rebounded 26% so far this year. |